{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:44:22Z","timestamp":1793933062863,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100015708","name":"World Heart Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jacc.2025.04.043","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:10:02Z","timestamp":1752592202000},"page":"149-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050"],"prefix":"10.1016","volume":"86","author":[{"given":"David A.","family":"Watkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Pickersgill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Gaziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-2519","authenticated-orcid":false,"given":"Mark D.","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shofiqul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Perel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto J.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9798","key":"10.1016\/j.jacc.2025.04.043_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"issue":"10304","key":"10.1016\/j.jacc.2025.04.043_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jacc.2025.04.043_bib5","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1016\/S2214-109X(21)00551-9","article-title":"Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data","volume":"10","author":"Marcus","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.jacc.2025.04.043_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jacc.2024.10.121","article-title":"Secondary prevention medications in 17 countries grouped by income level (PURE): a prospective cohort study","volume":"85","author":"Joseph","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"10258","key":"10.1016\/j.jacc.2025.04.043_bib7","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.04.043_bib8","series-title":"Secondary Prevention of Noncommunicable Diseases in Low- and Middle-income Countries Through Community-based and Health Service Interventions: Report of WHO-Wellcome Trust Meeting of Experts","year":"2001"},{"issue":"9326","key":"10.1016\/j.jacc.2025.04.043_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0140-6736(02)09358-3","article-title":"Two decades of progress in preventing vascular disease","volume":"360","author":"Yusuf","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.04.043_bib10","series-title":"The World Health Report 2002: Reducing Risks, Promoting Healthy Life","year":"2002"},{"issue":"7404","key":"10.1016\/j.jacc.2025.04.043_bib11","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"BMJ"},{"issue":"10073","key":"10.1016\/j.jacc.2025.04.043_bib12","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(17)30558-5","article-title":"Putting polypills into practice: challenges and lessons learned","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"10073","key":"10.1016\/j.jacc.2025.04.043_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(17)30553-6","article-title":"Uses of polypills for cardiovascular disease and evidence to date","volume":"389","author":"Huffman","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jacc.2025.04.043_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/heapol\/czac088","article-title":"Adoption and scale-up of the cardiovascular Polypill: a realist institutional analysis","volume":"38","author":"Abimbola","year":"2023","journal-title":"Health Policy Plan"},{"issue":"10306","key":"10.1016\/j.jacc.2025.04.043_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(21)01827-4","article-title":"Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis","volume":"398","author":"Joseph","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jacc.2025.04.043_bib16","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMoa2208275","article-title":"Polypill strategy in secondary cardiovascular prevention","volume":"387","author":"Castellano","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.04.043_bib17","series-title":"The Selection and Use of Essential Medicines 2023: Executive Summary of the Report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines, 24\u201328 April 2023","year":"2023"},{"issue":"10331","key":"10.1016\/j.jacc.2025.04.043_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0140-6736(21)02347-3","article-title":"NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jacc.2025.04.043_bib19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41591-022-01890-4","article-title":"Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes","volume":"28","author":"Pickersgill","year":"2022","journal-title":"Nat Med"},{"issue":"10226","key":"10.1016\/j.jacc.2025.04.043_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.04.043_bib23","author":"Pickersgill"},{"issue":"9","key":"10.1016\/j.jacc.2025.04.043_bib24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.jacc.2025.04.043_bib25","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-pressure and cholesterol lowering in persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"issue":"10199","key":"10.1016\/j.jacc.2025.04.043_bib26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial","volume":"394","author":"Roshandel","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jacc.2025.04.043_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008552","article-title":"compounding benefits of cholesterol-lowering therapy for the reduction of major cardiovascular events: systematic review and meta-analysis","volume":"15","author":"Wang","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"10.1016\/j.jacc.2025.04.043_bib28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jch.14320","article-title":"Clinical impact of medication adherence on 10-year cardio-cerebrovascular mortality in newly diagnosed hypertensive patients","volume":"23","author":"Kim","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.04.043_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2015.12.015","article-title":"Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: a prospective, individual patient data meta-analysis of 3140 patients in six countries","volume":"205","author":"Webster","year":"2016","journal-title":"Int J Cardiol"},{"issue":"10462","key":"10.1016\/j.jacc.2025.04.043_bib30","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(24)01439-9","article-title":"Global health 2050: the path to halving premature death by mid-century","volume":"404","author":"Jamison","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jacc.2025.04.043_bib31","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCULATIONAHA.121.054602","article-title":"Harmonization of the American College of Cardiology\/American Heart Association and European Society of Cardiology\/European Society of Hypertension blood pressure\/hypertension guidelines: comparisons, reflections, and recommendations","volume":"146","author":"Whelton","year":"2022","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.jacc.2025.04.043_bib32","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"10258","key":"10.1016\/j.jacc.2025.04.043_bib33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.04.043_bib34","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2022.125","article-title":"HEARTS in the Americas appraisal checklist and clinical pathway for comprehensive hypertension management in primary care","volume":"46","author":"Rosende","year":"2022","journal-title":"Rev Panam Salud Publica"},{"issue":"10205","key":"10.1016\/j.jacc.2025.04.043_bib35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(19)31949-X","article-title":"A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial","volume":"394","author":"Schwalm","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jacc.2025.04.043_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271908","article-title":"Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: a systematic literature review","volume":"17","author":"Jahangiri","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jacc.2025.04.043_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5334\/gh.1335","article-title":"A survey of availability and affordability of polypills for cardiovascular disease in selected countries","volume":"19","author":"Satheesh","year":"2024","journal-title":"Glob Heart"},{"issue":"2","key":"10.1016\/j.jacc.2025.04.043_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/13596535211062396","article-title":"The transformation of HIV therapy: one pill once a day","volume":"27","author":"Choudhary","year":"2022","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jacc.2025.04.043_bib39","series-title":"Rapid Assessment of Service Delivery for NCDs During the COVID-19 Pandemic","year":"2020"},{"key":"10.1016\/j.jacc.2025.04.043_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2023.1095236","article-title":"Cardiovascular disease, associated risk factors, and risk of dementia: an umbrella review of meta-analyses","volume":"3","author":"Brain","year":"2023","journal-title":"Front Epidemiol"},{"issue":"6","key":"10.1016\/j.jacc.2025.04.043_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/clc.22394","article-title":"Reducing cardiovascular and cancer risk: how to address global primary prevention in clinical practice","volume":"38","author":"Battistoni","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2025.04.043_bib42","author":"Pickersgill"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725063363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725063363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:32:50Z","timestamp":1784687570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725063363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0735109725063363"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.04.043","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}